ストックスクリーナーアプリを入手
4.36
4.06%
0.17
プレマーケット:
4.21
-0.15
-3.44%
前日終値:
$4.19
開ける：
$4.22
24時間の取引高:
165.02K
Relative Volume:
0.17
時価総額：
$65.21M
収益：
$44.52M
当期純損益:
$-2.86M
株価収益率:
-22.80
EPS:
-0.1912
ネットキャッシュフロー:
$4.75M
1週間 パフォーマンス:
+7.39%
1か月 パフォーマンス:
+40.65%
6か月 パフォーマンス:
+45.82%
1年 パフォーマンス:
-9.36%
1日の値動き範囲:
$4.07
$4.36
1週間の範囲:
$4.03
$4.36
52週間の値動き範囲:
$1.85
$6.265
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
名前
Cumberland Pharmaceuticals Inc
セクター
電話
615-255-0068
住所
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX vs TAK, ZTS, HLN, TEVA, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
4.36 | 65.21M | 44.52M | -2.86M | 4.75M | -0.1912 |
TAK
Takeda Pharmaceutical Co Adr
|
16.62 | 52.51B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
114.16 | 48.01B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.38 | 41.69B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.95 | 40.70B | 17.52B | 1.58B | 1.06B | 1.3428 |
UTHR
United Therapeutics Corp
|
570.40 | 24.21B | 3.18B | 1.33B | 1.04B | 27.90 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2012-11-12 | 繰り返されました | UBS | Neutral |
| 2011-02-01 | 繰り返されました | UBS | Neutral |
| 2010-12-16 | ダウングレード | UBS | Buy → Neutral |
| 2010-08-17 | ダウングレード | Jefferies | Buy → Hold |
| 2010-08-17 | 繰り返されました | Morgan Joseph | Buy |
| 2010-08-17 | 繰り返されました | UBS | Buy |
| 2010-05-14 | 繰り返されました | Morgan Joseph | Buy |
すべてを表示
Cumberland Pharmaceuticals Inc (CPIX) 最新ニュース
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE - Weekly Voice
After the bell May 5: Cumberland to host Q1 update at 4:30 ET - Stock Titan
Cumberland Pharmaceuticals (CPIX) Expected to Announce Earnings on Tuesday - MarketBeat
Cumberland Pharmaceuticals jumps on $100M Apotex transaction - MSN
Cumberland Shareholders Back Board, Auditor and Pay Policies - The Globe and Mail
Cumberland Pharmaceuticals Inc. Files 8-K Report with SEC Detailing Company Information and Shareholder Vote Results - Minichart
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above 200 Day Moving AverageHere's What Happened - MarketBeat
Cumberland Pharmaceuticals shareholders approve board nominees and other proposals - Investing.com
Cumberland Pharmaceuticals Shares Surge 80 Percent After Apotex Deal - HarianBasis.co
Shareholders at Cumberland (NASDAQ: CPIX) back board, auditor and pay - Stock Titan
Crude Oil Gains Over 1%; US Initial Jobless Claims Edge Higher - Sahm
Apotex inks strategic transaction with Cumberland Pharma - The Pharma Letter
Baker Donelson Represents Cumberland Pharmaceuticals in Strategic Transaction to Integrate Commercial Business with Apotex - Baker Donelson
Cumberland to sell drug portfolio to Apotex for $100m - Pharmaceutical Technology
Cumberland Pharmaceuticals stock soars on $100M Apotex deal By Investing.com - Investing.com South Africa
CPIX Price Today: Cumberland Pharmaceuticals Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Cumberland shares soar on $100M deal announcement - Nashville Post
Apotex Inc. enter into Asset Purchase Agreement to acquire Certain assets related to certain pharmaceutical products of Cumberland Pharmaceuticals Inc. for $100 million. - marketscreener.com
Cumberland Pharmaceuticals (CPIX) jumps on $100 million Apotex asset-sale deal - Quiver Quantitative
Cumberland Pharmaceuticals sells drug portfolio for $100M to Canadian giant - The Business Journals
Cumberland Pharmaceuticals (CPIX) Stock: Soars 57% After $100M Apotex Deal Announcement - parameter.io
Cumberland Pharmaceuticals to sell branded drug unit to Apotex for $100M - Investing.com
CPIX Jumps As FDA Expands Caldolor Postoperative Pain Label - StocksToTrade
Cumberland Pharmaceuticals to sell branded drug unit to Apotex for $100M By Investing.com - Investing.com South Africa
Cumberland Pharmaceuticals Sells Branded Portfolio to Apotex for $100 Million, Refocuses on Orphan Drug Development - Minichart
Cumberland Divests Branded Assets, Refocuses on Orphan Drugs - TipRanks
CPIX Stock Pops As FDA Expands Caldolor Pain Drug Label - timothysykes.com
Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses - PR Newswire
Cumberland Pharmaceuticals stock soars on $100M Apotex deal - Investing.com
Cumberland Pharmaceuticals to Sell Branded Product Assets to Apotex for $100 Million - TradingView
[8-K] CUMBERLAND PHARMACEUTICALS INC Reports Material Event - Stock Titan
Cumberland takes $100M cash deal, keeps three Phase II programs - Stock Titan
Dow Falls Over 200 Points; Tesla Shares Slip After Q1 Results - Sahm
Intravenous (IV) Ibuprofen Market Outlook 2026-2033: Growth - openPR.com
Is Cumberland (CPIX) stock a viable buying opportunity (+4.53%) 2026-04-18Community Sell Signals - Cổng thông tin điện tử tỉnh Lào Cai
Cumberland Pharmaceuticals gets FDA nod for expanded Caldolor use By Investing.com - Investing.com Australia
Cumberland Pharmaceuticals gets FDA nod for expanded Caldolor use - Investing.com
Cumberland Pharmaceuticals Inc Announces Expanded Indication for Caldolor Ibuprofen Injection - marketscreener.com
Risk Hedge: What are Cumberland Pharmaceuticals Incs growth leversQuarterly Trade Review & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
EPS Watch: Is Cumberland Pharmaceuticals Inc backed by strong institutional buying2026 Reactions & Smart Money Movement Tracker - baoquankhu1.vn
Insider Trends: What is the dividend yield of Cumberland Pharmaceuticals Inc2026 Momentum Check & Reliable Momentum Entry Alerts - baoquankhu1.vn
Will Cumberland (CPIX) Stock Outperform S&P 500 | Price at $3.06, Down 1.61%Shared Momentum Picks - Newser
Portfolio Shifts: What dividend growth rate does Cumberland Pharmaceuticals Inc offer2026 Snapshot & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Is Cumberland (CPIX) Stock at a Peak | Price at $3.23, Up 1.99%Viral Trade Signals - Cổng thông tin điện tử tỉnh Lào Cai
Can Cumberland Pharmaceuticals Inc beat the S P 5002026 Growth vs Value & Trade Opportunity Analysis - baoquankhu1.vn
CPIX PE Ratio & Valuation, Is CPIX Overvalued - Intellectia AI
Is Cumberland (CPIX) Stock Trending Down | Price at $3.09, Down 0.64%Trending Stock Ideas - Cổng thông tin điện tử Tỉnh Sơn La
Cumberland Pharmaceuticals Inc. (CPIX) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
CPIX Technical Analysis & Stock Price Forecast - Intellectia AI
Risks Report: Is Cumberland Pharmaceuticals Inc stock a top performer YTD2026 EndofYear Setup & Growth Focused Investment Plans - baoquankhu1.vn
Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma - Barchart.com
Cumberland Pharmaceuticals Inc (CPIX) 財務データ
収益
当期純利益
現金流量
EPS
0.63%
0.34%
大文字化:
|
ボリューム (24 時間):